Skip to content

Biogen Inc.

American multinational biotechnology company

BIIB Nasdaq SEC CIK 875045

Follow Biogen Weekly email: filings, results, news

News

6 stories filed under Biogen, grouped into ongoing threads

Investigational medicine

Thread · 2 stories

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Policy 20 d ago also on STOK

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Policy 23 d ago also on STOK

More coverage

Biogen stock hits 52-week high at 222.86 USD

Markets 22 d ago

Biogen’s (BIIB) Immunology Bet Meets A Pricier Balance Sheet

Markets 22 d ago

Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation

Markets 42 d ago also on ABBV

Biogen Completes Acquisition of RayThera Inc.

Deals 48 d ago

Next results

OCT28

Q3 2026 results

Wednesday · estimated from the filing cadence

Profile

Headquarters: CAMBRIDGE, MA, United States
Founded: 1978
CEO: Michel Vounatsos
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)
Website: biogen.com

Peers

Where this page comes from

Profile · SEC EDGAR, Wikidata

Next results · estimated from the filing cadence (SEC EDGAR)

News · 6 stories clustered from the RSS aggregator